Physician

Kruti Patel, DO

According to 2025 Medicare claims, Kruti Patel, DO (NPI: 1700273760) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY CARE INC (NPI: 1790778041; TIN: 311106418) and primary practice location at 45236-2725. Patel is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 127,600 HCPCS/CPT codes, and received $2,686,218 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,828 prescription claims across 282 beneficiaries totaling $9,561,911 in drug costs, led by Pomalyst (Pomalidomide). Open Payments data shows 62 records totaling $90,784. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $3,621 to $9,561,911. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2021 Medicare payment: $64,621 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,106,270 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,829,094 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,686,218 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021594,514$64,621
202231978,003$1,106,270
2023401102,701$1,829,094
2024379127,600$2,686,218

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.8M$9.6M2015 Drug cost: $3,621 (USD; Tot_Drug_Cst)2016 Drug cost: $28,812 (USD; Tot_Drug_Cst)2017 Drug cost: $39,517 (USD; Tot_Drug_Cst)2018 Drug cost: $48,561 (USD; Tot_Drug_Cst)2019 Drug cost: $7,879 (USD; Tot_Drug_Cst)2020 Drug cost: $745 (USD; Tot_Drug_Cst)2021 Drug cost: $54,384 (USD; Tot_Drug_Cst)2022 Drug cost: $3,306,012 (USD; Tot_Drug_Cst)2023 Drug cost: $5,593,188 (USD; Tot_Drug_Cst)2024 Drug cost: $9,561,911 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152079$3,621
201678565$28,812
201785539$39,517
201867478$48,561
20192877$7,879
2020N/R33$745
20211225$54,384
20221631,406$3,306,012
20232172,201$5,593,188
20242822,828$9,561,911

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more234916$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more164247$57
80053Blood test, comprehensive group of blood chemicals230914$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2421,260$8
83615Lactate dehydrogenase (enzyme) level117304$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide752,093$1,662,414
RevlimidLenalidomide782,184$1,413,090
LenalidomideLenalidomide441,232$723,044
CalquenceAcalabrutinib Maleate451,350$619,031
XpovioSelinexor15420$436,436

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$6,212GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.29$84,572SANOFI US SERVICES INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kruti Patel, DO?

Tedicare shows public-source Medicare data for Kruti Patel, DO (NPI 1700273760), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kruti Patel, DO have ACO affiliation data?

Kruti Patel, DO is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Kruti Patel, DO?

Kruti Patel, DO is linked to ONCOLOGY HEMATOLOGY CARE INC (billing NPI 1790778041) in the available physician profile data.

Does Kruti Patel, DO have Open Payments data?

Kruti Patel, DO has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.